Alphamab Oncology 2023 SR
The report highlights Alphamab Oncology's 2023 ESG performance, focusing on its mission to make cancer manageable and curable. Key achievements include the continued commercial success of ENWEIDA, the world's first subcutaneously injectable PD-L1 inhibitor, and significant clinical progress for candidates like KN046 and KN026. The company achieved substantial reductions in environmental impact, with greenhouse gas, energy, and water consumption intensities decreasing by over 70% compared to the 2020 baseline. Socially, the company donated over 220,000 vials of ENWEIDA, valued at RMB 132 million, and maintained a workforce where 85% are R&D personnel. Governance was strengthened through comprehensive anti-corruption training and a robust three-level ESG management structure.
Company: Alphamab Oncology
Sector: Manufacturing
Country: China
Year: 2023
Type: SR
Pages: 40
Back to company
Alphamab Oncology
ESG Report
The report highlights Alphamab Oncology's 2023 ESG performance, focusing on its mission to make cancer manageable and curable. Key achievements include the continued commercial success of ENWEIDA, the world's first subcutaneously injectable PD-L1 inhibitor, and significant clinical progress for candidates like KN046 and KN026. The company achieved substantial reductions in environmental impact, with greenhouse gas, energy, and water consumption intensities decreasing by over 70% compared to the 2020 baseline. Socially, the company donated over 220,000 vials of ENWEIDA, valued at RMB 132 million, and maintained a workforce where 85% are R&D personnel. Governance was strengthened through comprehensive anti-corruption training and a robust three-level ESG management structure.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees